Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4.

scientific article published on 09 March 2009

Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/IAI.00012-09
P932PMC publication ID2681753
P698PubMed publication ID19273558

P50authorDaria L ManaloQ89850271
Jonathan D KurtisQ124651007
Remigio M OlvedaQ124651008
Gretchen C. LangdonQ127461305
Luz P. AcostaQ127470500
Jennifer FriedmanQ42650087
P2093author name stringHai-Wei Wu
Tjalling Leenstra
Sunthorn Pond-Tor
Blanca Jarilla
Mario Jiz
Archie Pablo
P2860cites workPilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonicaQ24646962
A semi-automated multiplex high-throughput assay for measuring IgG antibodies against Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) domains in small volumes of plasmaQ28384693
Evidence for IgE-dependent cytotoxicity by rat eosinophilsQ70731646
Schistosoma japonicum egg antigens stimulate CD4 CD25 T cells and modulate airway inflammation in a murine model of asthmaQ79249028
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasisQ29619819
Paramyosin is a major target of the human IgA response against Schistosoma japonicumQ30822008
Identification of the Schistosoma japonicum 22.6-kDa antigen as a major target of the human IgE response: similarity of IgE-binding epitopes to allergen peptides.Q31994586
Regulation of the immune response in experimental and human schistosomiasis: the limits of an attractive paradigmQ33798142
Is there immunity to Schistosoma japonicum?Q33868240
Human immune responses to Schistosoma mansoni vaccine candidate antigensQ34004360
T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicumQ34301170
Blueprint for schistosomiasis vaccine developmentQ34646730
Mathematical modelling of schistosomiasis japonica: comparison of control strategies in the People's Republic of China.Q34646760
Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?Q36056272
Schistosomes: the road from host-parasite interactions to vaccines in clinical trialsQ36056288
Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodiesQ36353120
Interrelationship among asthma, atopy, and helminth infectionsQ36956282
Antigen-specific antibody isotype patterns to schistosoma japonicum recombinant and native antigens in a defined population in Leyte, the PhilippinesQ38859401
In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigensQ38866692
Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigensQ38879002
Human susceptibility to Schistosoma japonicum in China correlates with antibody isotypes to native antigensQ39177819
Expression, purification, and human antibody response to a 67 kDa vaccine candidate for schistosomiasis japonicaQ39477245
Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatmentQ39826161
Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobiumQ41162010
Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunityQ41255530
The global epidemiological situation of schistosomiasis and new approaches to control and researchQ42007538
Blocking activity of rat monoclonal antibodies in experimental schistosomiasisQ43523836
The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in BrazilQ44071866
Eosinophils as mediators of antibody-dependent damage to schistosomulaQ44775479
Human IgE response to the Schistosoma haematobium 22.6 kDa antigen.Q45243644
IgA antibodies to a protective antigen in human Schistosomiasis mansoniQ46627702
Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness.Q51827445
Human schistosomiasis: potential long-term consequences of vaccination programmes.Q52255329
Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum.Q54147190
Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.Q54230753
Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.Q54268997
Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.Q54457069
The isolation of a 22 kDa band after SDS-PAGE of Schistosoma mansoni adult worms and its use to demonstrate that IgE responses against the antigen(s) it contains are associated with human resistance to reinfectionQ58312879
Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoniQ58312953
Antibody-dependent cell-mediated damage to schistosomula in vitroQ59066650
The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytesQ67279316
Rat mast cell-eosinophil interaction in antibody-dependent eosinophil cytotoxicity to Schistosoma mansoni schistosomulaQ67418065
Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathwaysQ67691873
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectimmunoglobulin GQ79448
immunoglobulin EQ79455
tropomyosinQ418454
Schistosoma japonicumQ1256989
local diseaseQ11086612
helminth antigenQ64734112
P304page(s)2051-2058
P577publication date2009-03-09
P1433published inInfection and ImmunityQ6029193
P1476titleImmunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4.
P478volume77

Reverse relations

cites work (P2860)
Q24599525Allergenicity of carbohydrates and their role in anaphylactic events
Q39448421Allergic Sensitization Underlies Hyperreactive Antigen-Specific CD4+ T Cell Responses in Coincident Filarial Infection
Q28475501Analysis of complex patterns of human exposure and immunity to Schistosomiasis mansoni: the influence of age, sex, ethnicity and IgE
Q56909277Antibody Responses to Schistosoma mansoni Schistosomula Antigens
Q35088439Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil
Q34400053Bilharzia: Pathology, Diagnosis, Management and Control
Q38655300Characterization of Sarcoptes scabiei Tropomyosin and Paramyosin: Immunoreactive Allergens in Scabies
Q89599924Comparison of immune responses to Loa loa stage-specific antigen extracts in Loa loa-exposed BALB/c mice upon clearance of infection
Q52742149Cross-reactive antigens for natural IgE antibodies: allergens with the potential to transform a dormant to an active allergic response?
Q28538911Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity
Q26800164Development of Paramyosin as a Vaccine Candidate for Schistosomiasis
Q37680704Development of a specimen-sparing multichannel bead assay to detect antiparasite IgG4 for the diagnosis of Schistosoma and Wuchereria infections on the coast of Kenya
Q34500892Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray
Q92238880Effects of the Environment on Developmental Plasticity and Infection Success of Schistosoma Parasites - An Epigenetic Perspective
Q36506153Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections
Q34496255Efficacy and safety of arachidonic acid for treatment of Schistosoma mansoni-infected children in Menoufiya, Egypt
Q38193093Helminth Allergens, Parasite-Specific IgE, and Its Protective Role in Human Immunity
Q28542932Host determinants of reinfection with schistosomes in humans: a systematic review and meta-analysis
Q33634824Human IgE responses to different splice variants of Schistosoma mansoni tropomyosin: associations with immunity
Q36210573Human schistosome infection and allergic sensitisation
Q41373939Immuno-evasive tactics by schistosomes identify an effective allergy preventative
Q34782228Immunology of human schistosomiasis
Q33611746Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases
Q36283976Innate immunostimulatory properties of allergens and their relevance to food allergy
Q37994231Parasite glycans and antibody-mediated immune responses in Schistosoma infection
Q35487637Pilot Study on Interferon-γ-producing T Cell Subsets after the Protective Vaccination with Radiation-attenuated Cercaria of Schistosoma japonicum in the Miniature Pig Model
Q35626870Proteomic analysis of the excretory/secretory products and antigenic proteins of Echinococcus granulosus adult worms from infected dogs
Q34654313Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils
Q33723867Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective
Q34626126Repeated Schistosoma japonicum infection following treatment in two cohorts: evidence for host susceptibility to helminthiasis?
Q36158825Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies
Q33825627Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam.
Q90240652Schistosomiasis in the Philippines: Innovative Control Approach is Needed if Elimination is the Goal
Q28066042Schistosomiasis vaccines: where do we stand?
Q57152572The Interdependence between Schistosome Transmission and Protective Immunity
Q45904864Tissue expression and the host's immunological recognition of a Rhipicephalus microplus paramyosin.
Q34256750Use of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteins
Q39604709Vaccination with recombinant paramyosin in Montanide ISA206 protects against Schistosoma japonicum infection in water buffalo

Search more.